Cleared Traditional

K171647 - BeneLife Premium Facial Treatment Pack, Model: QZ0701A

K171647 is an FDA 510(k) clearance for BeneLife Premium Facial Treatment Pack, manufactured by Infinitus (China) Company , Ltd.. The device is a Class 2 Neurology device with product code NFO cleared through the Traditional 510(k) pathway after a 140-day FDA review.

K171647 · Infinitus (China) Company , Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
140d
Days
Class 2
Risk

K171647 is an FDA 510(k) clearance for the BeneLife Premium Facial Treatment Pack, Model: QZ0701A. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Infinitus (China) Company , Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on October 23, 2017 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K171647

510(k) Number K171647 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2017
Decision Date October 23, 2017
Days to Decision 140 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 149d · This submission: 140d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFO Device Classification - Class 2, Special Controls

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Guangzhou Leta Testing Technology Co., Ltd.
Jet Li

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 80
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K171647.
2 Face / Face Evolution
K171821 · Heat IN A Click · Apr 2018
Pobling MIITY 2
K163550 · Habalan Med & Beauty Co.,Ltd · Dec 2017
Smart Photon Micro-current Device, Model: EP-300
K162652 · Li-Tek Electronic Technology Corporation · Oct 2017
NuBODY Skin Toning Device
K171588 · Carol Cole Company Dba Nuface · Jul 2017
Galvanic Spa, Model: SKB-1405
K163470 · Shenzhen Siken 3D Technology Development Co., Ltd. · Jun 2017
ZIIP Device
K161484 · Ziip,Llc · Feb 2017